Adding storage to your home network will give you more than just a place to keep your Mac backups. Here's what to know when ...
Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced its financial and operational results for the third quarter of 2025, as well as a quarterly cash dividend of $0.03 per ...
The B.C. First Nations Justice Council has opened a new Indigenous Diversion Centre in downtown Prince George, B.C., which will offer some Indigenous people who commit minor crimes an alternative to ...
As the C language, which forms the basis of critical global software like operating systems, faces security limitations, ...
The BBC is preparing to cut its current affairs programming in the evening as the number of licence fee payers plummet. The corporation is grappling with a steep decline in its funding, with 300,000 ...
People get emotionally attached to their cars or motorcycles for different reasons, but a very common one is family history. The stunning airhead scrambler shown above belongs to Sam Russell, passed ...
With the launch of its first direct-to-patient (DTP) program, Genentech is joining the wave of drugmakers setting up direct-to-consumer sales of popular products at steep discounts for cash-paying ...
A grainy image comes into focus. Shaky interlacing lines coalesce into the vigorous movements of a lion dance. A time stamp reads “1990.8.19”, but the clang of cymbals and drums through the tinny ...
You should ask Tom Sarafian about his bread. The chef, who has perhaps passed the steaming rounds of aish baladi across the counter in the open kitchen himself, will tell you about the three types of ...
BYD Company (OTCPK:BYDDF) announced its largest vehicle recall to date, affecting more than 115,000 cars due to safety-related design and battery defects identified by China’s State Administration for ...
Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced its financial and operational results for the third quarter of 2025, as ...
Neuphoria Therapeutics’ lead candidate has failed to improve social anxiety symptoms in a late-stage trial, prompting the biotech to discontinue the program and launch a strategic review of its ...